| Configuration: ClusPro BM5 Table1 antibody | Protocol: ClusPro BM5 Unbound antibody top10 Dataset subset: BM5 Unbound antibody Table1 cohort | 12 CAPRI acceptable targets (all targets) count · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceClusPro Unbound antibody top10 Not reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Unbound antibody, first (top10) row; Good models Number |
|---|
| Configuration: ClusPro BM5 Table1 antibody | Protocol: ClusPro BM5 Unbound antibody top10 Dataset subset: BM5 Unbound antibody Table1 cohort | 0 CAPRI acceptable targets (by difficulty category) count · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceClusPro Unbound antibody top10 Not reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Unbound antibody, first (top10) row; difficult column; acceptable_or_better_targets |
|---|
| Configuration: ClusPro BM5 Table1 antibody | Protocol: ClusPro BM5 Unbound antibody top10 Dataset subset: BM5 Unbound antibody Table1 cohort | 0 CAPRI high-quality targets (by difficulty category) count · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceClusPro Unbound antibody top10 Not reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Unbound antibody, first (top10) row; difficult column; high_accuracy_targets |
|---|
| Configuration: ClusPro BM5 Table1 antibody | Protocol: ClusPro BM5 Unbound antibody top10 Dataset subset: BM5 Unbound antibody Table1 cohort | 0 CAPRI medium targets (difficult (flexible) targets; top 10 models; medium (**) as printed, overlap with high not stated) count · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceClusPro Unbound antibody top10 Not reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Unbound antibody, first (top10) row; difficult column; medium_accuracy_targets |
|---|
| Configuration: ClusPro BM5 Table1 antibody | Protocol: ClusPro BM5 Unbound antibody top10 Dataset subset: BM5 Unbound antibody Table1 cohort | 11 CAPRI acceptable targets (by difficulty category) count · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceClusPro Unbound antibody top10 Not reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Unbound antibody, first (top10) row; easy column; acceptable_or_better_targets |
|---|
| Configuration: ClusPro BM5 Table1 antibody | Protocol: ClusPro BM5 Unbound antibody top10 Dataset subset: BM5 Unbound antibody Table1 cohort | 0 CAPRI high-quality targets (by difficulty category) count · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceClusPro Unbound antibody top10 Not reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Unbound antibody, first (top10) row; easy column; high_accuracy_targets |
|---|
| Configuration: ClusPro BM5 Table1 antibody | Protocol: ClusPro BM5 Unbound antibody top10 Dataset subset: BM5 Unbound antibody Table1 cohort | 6 CAPRI medium targets (easy (rigid-body) targets; top 10 models; medium (**) as printed, overlap with high not stated) count · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceClusPro Unbound antibody top10 Not reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Unbound antibody, first (top10) row; easy column; medium_accuracy_targets |
|---|
| Configuration: ClusPro BM5 Table1 antibody | Protocol: ClusPro BM5 Unbound antibody top10 Dataset subset: BM5 Unbound antibody Table1 cohort | 1 CAPRI acceptable targets (by difficulty category) count · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceClusPro Unbound antibody top10 Not reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Unbound antibody, first (top10) row; intermediate column; acceptable_or_better_targets |
|---|
| Configuration: ClusPro BM5 Table1 antibody | Protocol: ClusPro BM5 Unbound antibody top10 Dataset subset: BM5 Unbound antibody Table1 cohort | 0 CAPRI high-quality targets (by difficulty category) count · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceClusPro Unbound antibody top10 Not reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Unbound antibody, first (top10) row; intermediate column; high_accuracy_targets |
|---|
| Configuration: ClusPro BM5 Table1 antibody | Protocol: ClusPro BM5 Unbound antibody top10 Dataset subset: BM5 Unbound antibody Table1 cohort | 0 CAPRI medium targets (intermediate targets; top 10 models; medium (**) as printed, overlap with high not stated) count · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceClusPro Unbound antibody top10 Not reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Unbound antibody, first (top10) row; intermediate column; medium_accuracy_targets |
|---|
| Configuration: ClusPro BM5 Table1 antibody | Protocol: ClusPro BM5 Unbound antibody top10 Dataset subset: BM5 Unbound antibody Table1 cohort | 46.1% CAPRI top-10 success rate percent · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceClusPro Unbound antibody top10 Not reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Unbound antibody, first (top10) row; Good models % |
|---|